CST3 and Nephropathy: Currently, development and validation of high-throughput innovative technologies allow rapid multiplexed detection of multiple markers like Cystatin C, netrin-1, IL-18 and Kim-1 in the blood and urine which has more specificity and sensitivity to detect early changes of kidney damage and associated dysfunction [35,36,37].